NCT01426906View on ClinicalTrials.gov

Pharmacokinetic Drug Interaction Study in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Healthy Male Volunteers

Interventions

DRUG

Ketoconazole

Period 1 : LC15-0444 Period 2 : LC15-0444 with ketoconazole

DRUG

rifampicin

Period 1 : LC15-0444 Period 2 : LC15-0444 with rifampicin

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors

Lead Sponsor

LG Life Sciences

All Listed Sponsors

lead

LG Life Sciences

INDUSTRY

NCT01426906 - Pharmacokinetic Drug Interaction Study in Healthy Male Subjects | Biotech Hunter | Biotech Hunter